The phase III ARNASA study did not meet the primary endpoint of a statistically significant reduction in the AER at 52 weeks
FDA requests Sarepta Therapeutics to suspend distribution of Elevidys and places clinical trials on hold for multiple gene therapy products following 3 deaths
atai and Beckley Psytech plan to meet with the U.S. Food and Drug Administration (FDA) and other regulatory agencies to finalize the Phase 3 trial design.
A triple-action Formula for comprehensive respiratory relief
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody, targeting a known biological driver of Parkinson’s disease progression
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
Subscribe To Our Newsletter & Stay Updated
